Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms - PubMed (original) (raw)
Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms
Timothy I Meier et al. Protein Expr Purif. 2004 Jun.
Abstract
The Class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that phosphorylate the 3-hydroxyl group of the inositol ring of phosphatidylinositides. Although closely related, experimental evidence suggests that the four Class I PI3Ks may be functionally distinct. To further study their unique biochemical properties, the three human Class Ia PI3K (alpha, beta, and delta) p110 catalytic domains were cloned and co-expressed with the p85alpha regulatory domain in Sf9 cells. None of the p110 subunits were successfully expressed in the absence of p85alpha. Successful expression and purification of each p85alpha/p110 protein required using an excess of the p110 vector over the p85 vector during co-infection of Sf9 cells. Proteins were purified as the p85alpha/p110 complex by nickel affinity chromatography through an N-terminal His-tag on the p110 subunit using an imidazole gradient. The purification yields were high using the optimized ratio of p85/p110 vector and small culture volumes, with 24mg/L cell culture media for p85alpha/p110alpha, 17.5mg/L for p85alpha/p110delta, and 3.5mg/L for p85alpha/p110beta. The identity of each purified isoform was confirmed by mass spectral analysis and immunoblotting. The activities of the three p85alpha/p110 proteins and the Class Ib p110gamma catalytic domain were investigated using phosphatidylinositol 4,5-bisphosphate (PIP2) as the substrate in a PIP2/phosphatidylserine (PS) liposome. All four enzymes exhibited reaction velocities that were dependent on the surface concentration of PIP2. The surface concentrations that gave maximal activity for each human isoform with 0.5mM PIP2 were 2.5mol% PIP2 for p110gamma, 7.5mol% for p85alpha/p110beta, and 10mol% PIP2 for p85alpha/p110alpha and p85alpha/p110delta. The specific activity of p85alpha/p110alpha was three to five times higher than that of the other human isoforms. These kinetic differences may contribute to the unique roles of these isoforms in cells.
Similar articles
- The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function.
Beeton CA, Das P, Waterfield MD, Shepherd PR. Beeton CA, et al. Mol Cell Biol Res Commun. 1999 May;1(2):153-7. doi: 10.1006/mcbr.1999.0124. Mol Cell Biol Res Commun. 1999. PMID: 10356365 - Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
Geering B, Cutillas PR, Vanhaesebroeck B. Geering B, et al. Biochem Soc Trans. 2007 Apr;35(Pt 2):199-203. doi: 10.1042/BST0350199. Biochem Soc Trans. 2007. PMID: 17371237 Review. - New responsibilities for the PI3K regulatory subunit p85 alpha.
Okkenhaug K, Vanhaesebroeck B. Okkenhaug K, et al. Sci STKE. 2001 Jan 16;2001(65):pe1. doi: 10.1126/stke.2001.65.pe1. Sci STKE. 2001. PMID: 11752634 Review.
Cited by
- Inhibitors of phosphatidylinositol-3-kinase in cancer therapy.
Ihle NT, Powis G. Ihle NT, et al. Mol Aspects Med. 2010 Apr;31(2):135-44. doi: 10.1016/j.mam.2010.02.003. Epub 2010 Feb 20. Mol Aspects Med. 2010. PMID: 20176047 Free PMC article. Review. - PI3K-AKT-mediated phosphorylation of Thr260 in CgCaspase-3/6/7 regulates heat-induced activation in oysters.
Wang C, Du M, Jiang Z, Cong R, Wang W, Zhang T, Chen J, Zhang G, Li L. Wang C, et al. Commun Biol. 2024 Nov 7;7(1):1459. doi: 10.1038/s42003-024-07184-4. Commun Biol. 2024. PMID: 39511363 Free PMC article. - Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases.
Salamon RS, Backer JM. Salamon RS, et al. Bioessays. 2013 Jul;35(7):602-11. doi: 10.1002/bies.201200176. Bioessays. 2013. PMID: 23765576 Free PMC article. Review. - Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.
Chaussade C, Rewcastle GW, Kendall JD, Denny WA, Cho K, Grønning LM, Chong ML, Anagnostou SH, Jackson SP, Daniele N, Shepherd PR. Chaussade C, et al. Biochem J. 2007 Jun 15;404(3):449-58. doi: 10.1042/BJ20070003. Biochem J. 2007. PMID: 17362206 Free PMC article. - Novel targeted therapies of T cell lymphomas.
Iżykowska K, Rassek K, Korsak D, Przybylski GK. Iżykowska K, et al. J Hematol Oncol. 2020 Dec 31;13(1):176. doi: 10.1186/s13045-020-01006-w. J Hematol Oncol. 2020. PMID: 33384022 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases